MDR-TB treatment efficacy by results of Xpert MTB/RIF assayin the Stavropol region of the Russian Federation

O. Komissarova (Moscow, Russian Federation), R. Abdullaev (Moscow, Russian Federation), Y. Chumakova (Moscow, Russian Federation), V. Odinets (Moscow, Russian Federation)

Source: International Congress 2018 – Drug-resistant tuberculosis and the sequelae of pulmonary tuberculosis
Session: Drug-resistant tuberculosis and the sequelae of pulmonary tuberculosis
Session type: Thematic Poster
Number: 4748
Disease area: Respiratory infections

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
O. Komissarova (Moscow, Russian Federation), R. Abdullaev (Moscow, Russian Federation), Y. Chumakova (Moscow, Russian Federation), V. Odinets (Moscow, Russian Federation). MDR-TB treatment efficacy by results of Xpert MTB/RIF assayin the Stavropol region of the Russian Federation. 4748

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
MDR-TB treatment efficacy according of conventional method and Xpert MTB/RIF results in Republic of Moldova.
Source: International Congress 2017 – MDRTB: detection and management
Year: 2017

Tuberculosis diagnosis in rural Namibia using gene Xpert MTB/RIF testing
Source: International Congress 2016 – Microbiology: bronchoalveolar lavage (BAL) and PCR
Year: 2016

Cost–benefit analysis of Xpert MTB/RIF for tuberculosis suspects in German hospitals
Source: Eur Respir J 2016; 47: 575-587
Year: 2016



The application of the the Xpert MTB/RIF in the Moscow Scientific and Clinical Antituberculosis Center
Source: Annual Congress 2013 –Tuberculosis: clinical aspects
Year: 2013

Xpert MTB/RIF performance to diagnose tuberculosis and rifampicin resistance in a reference centre in southern Brazil
Source: ERJ Open Res, 5 (3) 00043-2019; 10.1183/23120541.00043-2019
Year: 2019



Use of Xpert MTB/RIF Ultra assays among paediatric tuberculosis experts in Europe
Source: Eur Respir J, 51 (5) 1800346; 10.1183/13993003.00346-2018
Year: 2018



Influence of early diagnostics with Xpert MTB/RIF on MDR TB patients treatment efficacy
Source: International Congress 2015 – WHO guidelines in TB and clinical practice
Year: 2015

How is Xpert MTB/RIF being implemented in 22 high tuberculosis burden countries?
Source: Eur Respir J 2015; 45: 549-554
Year: 2015


Comparative study of gene Xpert MTB/RIF, smear microscopy and TB MGIT culture in diagnosis of tuberculosis in India
Source: International Congress 2015 – WHO guidelines in TB and clinical practice
Year: 2015


A comparison between the efficiency of the Xpert MTB/RIF assay and nested PCR in identifying mycobacterium tuberculosis during routine clinical practice
Source: International Congress 2014 – Tuberculosis: from epidemiology to therapy 2
Year: 2014

Treatment outcomes of the use of moxifloxacin in management of patients with XDR-TB in Tomsk Oblast of the Russian Federation
Source: Annual Congress 2008 - Multidrug-resistant and the emerging threat of extensively drug-resistant tuberculosis
Year: 2008



Clinical utility of the Xpert MTB/RIF test in induced sputum
Source: International Congress 2015 – WHO guidelines in TB and clinical practice
Year: 2015


Xpert MTB/RIF testing of pooled induced sputum
Source: International Congress 2014 – Tuberculosis: diagnosis
Year: 2014

Evaluation of Xpert MTB/RIF assay performance in diagnosing extrapulmonary tuberculosis among adults in a tertiary care centre in India
Source: Eur Respir J 2014; 44: 1090-1093
Year: 2014


Effectiveness of national standardized and WHO regimens and risk factors of unfavorable outcomes in treatment of patients with MDR-TB in Novosibirsk Oblast, Russian Federation
Source: International Congress 2014 – Mycobacterium tuberculosis infection and disease: clinical epidemiology 1
Year: 2014


Early tuberculosis treatment monitoring by Xpert® MTB/RIF
Source: Eur Respir J 2012; 39: 1269-1271
Year: 2012


Xpert MTB/RIF for diagnosis of tuberculosis and drug-resistant tuberculosis: a cost and affordability analysis
Source: Eur Respir J 2013; 42: 708-720
Year: 2013



Is Xpert MTB/Rif Ultra superior to Xpert MTB/Rif for the diagnosis of tuberculosis in children in Uzbekistan
Source: Virtual Congress 2021 – Paediatric respiratory infections: chronic infection, vaccination and lung function
Year: 2021

Role of GeneXpert MTB/RIF assay for rapid diagnosis of tuberculosis and detection of rifampacin(R) resistance in patients in high risk DRTB
Source: International Congress 2014 – Tuberculosis: from epidemiology to therapy 2
Year: 2014

Improvement of TB epidemiological situation in Tomsk Oblast within the MDR-TB treatment program
Source: Annual Congress 2008 - Asthma and miscellaneous disorders
Year: 2008